Cowen Inc, a that provides sales, trading and prime brokerage services, announced on Tuesday that it made two hires to its senior management team. Bobby Croswell has joined the firm’s outsourced trading group as a Managing Director and Head of Business Development, whilst Dr Yaron Werber has been appointed as a senior biotechnology analyst.
Bobby Croswell
Croswell has a lot of experience in the finance industry. In his new role, he will be located in the firm’s Boston office. He will be responsible for expanding the outsourced trading business, both within the US and throughout the world.
With the addition of Croswell, Cowen’s outsourced trading team is comprised of 20 professionals. They are based in the US, London, Belfast and soon to be Hong Kong. Most recently, Croswell was a Partner and Managing Director at . He worked in the company’s outsourced trading division for close to 12 years.
Source: LinkedIn
Dr Yaron Werber
Werber will be joining Cowen’s equity research team in his new position, which will be effective on September 24, 2018. At Cowen, he will be based in New York and report to Robert Fagin, Cowen’s Director of Research.
Source: LinkedIn
He joined the company in 2015 following nearly 15 years spent as a highly-ranked biotechnology research analyst at Cowen and then between 2004 until 2015. Werber has also been a Venture Advisor for the Israel Biotech Fund since 2015.
Source: LinkedIn
“As a trained medical doctor, respected public company CFO and a proven sell-side analyst, Yaron is an outstanding addition to Cowen’s leading healthcare and biotech research team, and will be part of a highly collaborative group of industry experts dedicated to helping us deliver on our number one priority for clients: outperformance.”
Be First to Comment